Q2 2015 Holdings
Filed 2015-08-11 | 9 holdings | $224.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $36.8K | 2,269,578 | 16.4% |
| Pulmatrix Inc. | Common Stock | 74584P103 | $34.6K | 3,607,996 | 15.4% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $33.9K | 1,827,992 | 15.1% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $27.0K | 1,968,606 | 12.1% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $25.9K | 1,230,009 | 11.5% |
| Trevena, Inc. | Common Stock | 89532E109 | $23.6K | 3,769,280 | 10.5% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $16.0K | 2,473,186 | 7.1% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $15.1K | 3,287,529 | 6.7% |
| Bind Therapeutics, Inc. | Common Stock | 05548N107 | $11.3K | 2,018,253 | 5.0% |